Broughton releases infographic to help establish comprehensive safety standards for CBD ~.
Cannabis/CBD
Sample Analysis
Reliable Profiling, Qualification, and Quantification
Accurate and reliable testing results are essential for developing safe, high-quality medicinal cannabis, CBD, and hemp products. An in-depth understanding of your product is essential for regulatory compliance and builds trust with regulators and the people who use your products.
Arrange a meeting with a scientific or regulatory expert to discuss your project and learn how we can help accelerate your product to market to maximize your success.
Cannabinoid Testing Services Resources
Learn more about how we can help bring your medicinal cannabis or CBD product to market through our high-quality analytical testing services.
Cannabis Services
Enhancing the positive reputation of cannabis by accelerating safe, efficacious, and high-quality cannabis products to a regulated market. Learn more about our cannabis services.
Whitepaper: Does CBD Really Harm the Liver?
Both the FDA and EFSA have raised several concerns about CBD as supplements and as an ingredient in food and drinks, citing potential liver damage as a possible side effect. Is CBD really that toxic to the liver? To find out, toxicologist Cristelle Santos looks at the scientific evidence.
Whitepaper: A Summary of the Legal Status and Regulatory Pathways to Market for Cannabinoid Products in the UK Market
Broughton summarises the regulatory pathways available for cannabinoid products in the UK market and the legal requirements for each potential market route.
Whitepaper: Review of the degradation pathways of cannabinoids, the potential impact on medicinal and consumer products, and discussion of mitigation solutions
In this whitepaper, Broughton discusses the susceptibility of cannabinoids to degrade and summarizes the main degradation pathways of the primary cannabinoid products on the market; tetrahydrocannabinol (THC) and Cannabidiol (CBD).
Whitepaper: The importance of the human endocannabinoid system when developing therapeutic cannabis products
To develop cannabis products that can both enhance the quality of life of cannabis users and comply with current and future regulations, we believe that fi rst we need to understand what cannabis is, how people use it, and how it affects the human body and mind. This white paper aims to provide essential but concise information about these areas, supported by scientific evidence.
Medicinal Cannabis and CBD Services
Learn more about our UK and EU Novel Food Application scientific consultancy and analytical testing support.
Cannabidiol (CBD) is the second most prevalent active ingredient (the first being tetrahydrocannabinol or THC) in the cannabis plant (e.
Introduction The increasing popularity and availability of cannabidiol (CBD) products has raised concerns regarding their safety, quality control, ....